At MED Institute, we are dedicated to bringing new medical products to market that are safe and effective for patients. We leverage our engineering, regulatory, and clinical expertise to support companies who need help moving their product from concept to commercialization.
Founded by President Neal Fearnot, MED Institute began as a company to translate medical device ideas from the lab, bench, or back of a napkin into commercial devices. Our experienced team has developed and gained approval on numerous U.S. Class I, II, and III devices over the last 35 years, as well as international equivalents and pharmaceutical and biological therapies. MED has developed many first to market devices, such as the first peripheral drug coated stent, the first coronary stent, endovascular grafts and many delivery systems. Our optimized product development services coordinated with regulatory approval and early clinical evaluation processes, helps reduce cost and time to accelerate your technology into the product life cycle.
We support entrepreneurs, consultants, developers, and manufacturers of medical products through the entire product life cycle; providing services as needed from initial concept through product approval to post market needs.
We are committed to consistently performing services with high quality, that deliver exceptional results, and add value to the client’s business.
For client surveys sent in the last two quarters, we received ratings of 4.89/5 points (11).